TRIP6 enhances lysophosphatidic acid-induced cell migration by interacting with the lysophosphatidic acid 2 receptor

被引:80
作者
Xu, J
Lai, YJ
Lin, WC
Lin, FT
机构
[1] Univ Alabama Birmingham, Dept Cell Biol, Birmingham, AL 35294 USA
[2] Univ Alabama Birmingham, Div Hematol & Oncol, Dept Med, Birmingham, AL 35294 USA
关键词
D O I
10.1074/jbc.M311891200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Lysophosphatidic acid (LPA) induces actin rearrangement, focal adhesion assembly, and cell migration through the activation of small G protein Rho and its downstream effectors. These diverse cellular responses are mediated by its associated G protein-coupled receptors. However, the mechanisms and specificity by which these LPA receptors mediate LPA actions are still poorly understood. Here we show that LPA stimulation promotes the interaction of the LPA(2) receptor with a focal adhesion molecule, TRIP6 (thyroid receptor interacting protein 6)/ZRP-1 (zyxin-related protein 1). TRIP6 directly binds to the carboxyl-terminal tail of the LPA(2) receptor through its LIM domains. LPA-dependent recruitment of TRIP6 to the plasma membrane promotes its targeting to focal adhesions and co-localization with actin stress fibers. In addition, TRIP6 associates with the components of focal complexes including paxillin, focal adhesion kinase, c-Src, and p130(cas) in an agonist-dependent manner. Overexpression of TRIP6 augments LPA-induced cell migration; in contrast, suppression of endogenous TRIP6 expression by a TRIP6-specific small interfering RNA reduces it in SKOV3 ovarian cancer cells. Strikingly, the association with TRIP6 is specific to the LPA(2) receptor but not LPA(1) or LPA(3) receptor, indicating a specific role for TRIP6 in regulating LPA(2) receptor-mediated signaling. Taken together, our results suggest that TRIP6 functions at a point of convergence between the activated LPA(2) receptor and downstream signals involved in cell adhesion and migration.
引用
收藏
页码:10459 / 10468
页数:10
相关论文
共 35 条
[1]   Identification of cDNAs encoding two G protein-coupled receptors for lysosphingolipids [J].
An, SZ ;
Bleu, T ;
Huang, W ;
Hallmark, OG ;
Coughlin, SR ;
Goetzl, EJ .
FEBS LETTERS, 1997, 417 (03) :279-282
[2]   Characterization of a novel subtype of human G protein-coupled receptor for lysophosphatidic acid [J].
An, SZ ;
Bleu, T ;
Hallmark, OG ;
Goetzl, EJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (14) :7906-7910
[3]   The LIM domain: regulation by association [J].
Bach, I .
MECHANISMS OF DEVELOPMENT, 2000, 91 (1-2) :5-17
[4]   Molecular cloning and characterization of a novel human G-protein-coupled receptor, EDG7, for lysophosphatidic acid [J].
Bandoh, K ;
Aoki, J ;
Hosono, H ;
Kobayashi, S ;
Kobayashi, T ;
Murakami-Murofushi, K ;
Tsujimoto, M ;
Arai, H ;
Inoue, K .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (39) :27776-27785
[5]   Zyxin: zinc fingers at sites of cell adhesion [J].
Beckerle, MC .
BIOESSAYS, 1997, 19 (11) :949-957
[6]   Identification of LIM3 as the principal determinant of paxillin focal adhesion localization and characterization of a novel motif on paxillin directing vinculin and focal adhesion kinase binding [J].
Brown, MC ;
Perrotta, JA ;
Turner, CE .
JOURNAL OF CELL BIOLOGY, 1996, 135 (04) :1109-1123
[7]   A system for stable expression of short interfering RNAs in mammalian cells [J].
Brummelkamp, TR ;
Bernards, R ;
Agami, R .
SCIENCE, 2002, 296 (5567) :550-553
[8]   Lysophosphatidic acid receptors [J].
Contos, JJA ;
Ishii, I ;
Chun, J .
MOLECULAR PHARMACOLOGY, 2000, 58 (06) :1188-1196
[9]   Genomic characterization of the lysophosphatidic acid receptor gene, IpA2/Edg4, and identification of a frameshift mutation in a previously characterized cDNA [J].
Contos, JJA ;
Chun, J .
GENOMICS, 2000, 64 (02) :155-169
[10]  
Cox EA, 1998, MICROSC RES TECHNIQ, V43, P412, DOI 10.1002/(SICI)1097-0029(19981201)43:5<412::AID-JEMT7>3.0.CO